![Woo-Jin Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 17 182 $ al 30/06/2026
Woo-Jin Kim formerly worked at KB Insurance Co., Ltd., as President & Co-Chief Executive Officer and SAMSUNG PHARMACEUTICAL Co., Ltd., as Independent Director.
Mr. Kim received his graduate degree from Seoul National University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GENOLUTION, Inc.
 GENOLUTION, Inc. BiotechnologyHealth Technology Develops new drugs 0,11 % | 29/06/2026 | 22.000 ( 0,11 % ) | 17 182 $ | 30/06/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| SAMSUNG PHARM. CO., LTD. | Director/Miembro de la Junta | - |
| KB INSURANCE CO LTD | Presidente | 04/07/2012 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 3 |
|---|---|
KB Insurance Co., Ltd.
 KB Insurance Co., Ltd. Multi-Line InsuranceFinance Operates as a non-life insurance carrier | Finance |
SAMSUNG PHARMACEUTICAL Co., Ltd.
 SAMSUNG PHARMACEUTICAL Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
